Avalon Trust Co Purchases 200 Shares of Church & Dwight Co., Inc. (NYSE:CHD)

Avalon Trust Co lifted its position in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 33.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 800 shares of the company’s stock after purchasing an additional 200 shares during the period. Avalon Trust Co’s holdings in Church & Dwight were worth $84,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently made changes to their positions in the company. one8zero8 LLC bought a new position in shares of Church & Dwight during the fourth quarter worth approximately $1,798,000. Natixis Advisors LLC increased its stake in shares of Church & Dwight by 2.3% during the fourth quarter. Natixis Advisors LLC now owns 168,145 shares of the company’s stock worth $17,606,000 after purchasing an additional 3,816 shares during the period. Commonwealth Equity Services LLC increased its stake in shares of Church & Dwight by 5.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 75,596 shares of the company’s stock worth $7,916,000 after purchasing an additional 4,176 shares during the period. Impact Capital Partners LLC acquired a new stake in Church & Dwight during the fourth quarter worth approximately $361,000. Finally, Avantax Advisory Services Inc. grew its position in Church & Dwight by 5.8% during the fourth quarter. Avantax Advisory Services Inc. now owns 14,500 shares of the company’s stock worth $1,518,000 after buying an additional 798 shares in the last quarter. Institutional investors own 86.60% of the company’s stock.

Church & Dwight Stock Down 0.6 %

Shares of NYSE:CHD opened at $109.15 on Friday. The firm has a market cap of $26.85 billion, a P/E ratio of 46.05, a P/E/G ratio of 3.32 and a beta of 0.57. The company has a quick ratio of 1.24, a current ratio of 1.70 and a debt-to-equity ratio of 0.51. Church & Dwight Co., Inc. has a 12-month low of $96.35 and a 12-month high of $116.46. The business has a fifty day simple moving average of $106.84 and a 200 day simple moving average of $105.68.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.77 earnings per share for the quarter, hitting the consensus estimate of $0.77. Church & Dwight had a return on equity of 20.03% and a net margin of 9.58%. During the same period last year, the firm posted $0.65 earnings per share. Analysts predict that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current year.

Church & Dwight Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 3rd. Investors of record on Friday, February 14th were given a $0.295 dividend. This represents a $1.18 dividend on an annualized basis and a yield of 1.08%. This is a positive change from Church & Dwight’s previous quarterly dividend of $0.28. The ex-dividend date was Friday, February 14th. Church & Dwight’s payout ratio is presently 49.79%.

Analyst Ratings Changes

A number of brokerages recently issued reports on CHD. Stifel Nicolaus increased their price target on Church & Dwight from $103.00 to $105.00 and gave the stock a “hold” rating in a research report on Monday, February 3rd. Piper Sandler reduced their price target on Church & Dwight from $128.00 to $126.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. JPMorgan Chase & Co. reduced their price target on Church & Dwight from $107.00 to $106.00 and set an “underweight” rating on the stock in a research report on Friday, February 21st. Royal Bank of Canada reissued a “sector perform” rating and set a $105.00 price target on shares of Church & Dwight in a research report on Monday, February 3rd. Finally, Barclays increased their price target on Church & Dwight from $90.00 to $93.00 and gave the stock an “underweight” rating in a research report on Tuesday, February 4th. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $111.56.

Insider Activity at Church & Dwight

In other Church & Dwight news, EVP Maynadier Patrick D. De sold 54,510 shares of the business’s stock in a transaction that occurred on Monday, March 10th. The stock was sold at an average price of $115.98, for a total transaction of $6,322,069.80. Following the completion of the sale, the executive vice president now directly owns 10,497 shares of the company’s stock, valued at approximately $1,217,442.06. The trade was a 83.85 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, December 16th. The stock was sold at an average price of $106.11, for a total value of $1,061,100.00. Following the sale, the director now directly owns 32,500 shares of the company’s stock, valued at $3,448,575. This represents a 23.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 75,570 shares of company stock valued at $8,599,549 in the last three months. Corporate insiders own 1.40% of the company’s stock.

Church & Dwight Company Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.